About Us
About Us
“Make a difference to the world and provide a platform for all the employees” is the spirit of Diff Biotech.
“Make a difference to the world” is Diff’s product design philosophy. Our product pipeline has differentiated competitive advantages and world-class innovation.
Our team was founded with a vision to harness the power of life sciences to make a difference to the world and deliver value in the prevention and control of viral diseases. We strive to pioneer virology tools to accelerate antiviral drug discovery and vaccine development.
Our technology, capable of driving the birth of the next-gen of biopharma and delivering multiple services.
Viraltech Architect
The DIFF ‘Viraltech Architect’ is versatile, facilitating genetic engineering manipulations on a wide range of viruses. This adaptability makes it applicable across different innovative drug domains, including vaccines, oncolytic viruses, and gene therapy.
DCVL
By employing the DCVL (Design-Construct-Verify-Learn) methodology, the ‘Viraltech Architect’refines viruses to facilitate advancements in scientific research. Through a blend of dry and wet experiments, experimental design ideas are validated in wet experiments.
DIFF DataBase
As of January 2024, over 2000 rounds of data from wet experiments are preserved in the DIFF Database, positioning this as our future core competitive strength.
What we are good at
Developing vaccine candidates
Create tailored immunization solutions with our specialized services for vaccine candidate development. DIFF offers a comprehensive approach through four key modules: constructing strain (plasmid), virus rescue, biological characterization, and animal testing.
Antiviral drug screening
DIFF Biotech has pioneered an antiviral drug screening service utilizing the DIFF Reporter Virus, DIFF Pseudoviruses, and DIFF ReporterVision™, catering to the preclinical research and development needs of antiviral drugs.